The fact that multiple Colgate-Palmolive Company (NYSE:CL) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. Knowing whether insiders are buying is usually more helpful when evaluating insider transactions, as insider selling can have various explanations. However, shareholders should take a deeper look if several insiders are selling stock over a specific time period.
While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.
The Last 12 Months Of Insider Transactions At Colgate-Palmolive
In the last twelve months, the biggest single sale by an insider was when the Chairman, Noel Wallace, sold US$1.2m worth of shares at a price of US$84.17 per share. So it's clear an insider wanted to take some cash off the table, even below the current price of US$96.49. We generally consider it a negative if insiders have been selling, especially if they did so below the current price, because it implies that they considered a lower price to be reasonable. While insider selling is not a positive sign, we can't be sure if it does mean insiders think the shares are fully valued, so it's only a weak sign. This single sale was just 3.6% of Noel Wallace's stake.
Insiders in Colgate-Palmolive didn't buy any shares in the last year. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
![big](https://newsfile.futunn.com/public/NN-PersistNewsContentImage/7781/20240727/0-bc6961d987fa72b6be342d0fdded9a42-0-255e0de07e0954c4b27d6f18386fdfba.png/big)
For those who like to find hidden gems this free list of small cap companies with recent insider purchasing, could be just the ticket.
Colgate-Palmolive Insiders Are Selling The Stock
The last quarter saw substantial insider selling of Colgate-Palmolive shares. In total, insider John Kooyman sold US$327k worth of shares in that time, and we didn't record any purchases whatsoever. In light of this it's hard to argue that all the insiders think that the shares are a bargain.
Insider Ownership
Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. We usually like to see fairly high levels of insider ownership. It appears that Colgate-Palmolive insiders own 0.09% of the company, worth about US$74m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.
What Might The Insider Transactions At Colgate-Palmolive Tell Us?
An insider sold Colgate-Palmolive shares recently, but they didn't buy any. And there weren't any purchases to give us comfort, over the last year. But it is good to see that Colgate-Palmolive is growing earnings. Insider ownership isn't particularly high, so this analysis makes us cautious about the company. So we'd only buy after careful consideration. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. For example - Colgate-Palmolive has 1 warning sign we think you should be aware of.
Of course Colgate-Palmolive may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com